2 August 2013
Further to the announcement made on 31 May 2013 about a preliminary approach for the Medical division, Smiths Group announces that it has not proved possible to reach agreement with the potential counterparty on acceptable terms for a transaction. Discussions have therefore been terminated.
In reaching this conclusion, the Board has taken full account of the quality and highly cash generative nature of Smiths Medical, both standalone and in the context of the Group as a whole.
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Smiths Group supports NASA’s Europa Clipper mission to explore Jupiter’s moon, Europa
Find out more
Smiths Detection awarded service subcontract
Providing preventative and corrective maintenance for 486 hold baggage scanning systems across 41 airports in the United States
Find out more
Smiths Group publishes 2024 ‘Sustainability at Smiths’ report
Smiths Group publishes its latest ‘Sustainability at Smiths’ report for the fiscal year 2024. The report outlines the progress that Smiths Group has made during the year on its ESG agenda.
Find out more
